Bulletin
Investor Alert

Tiziana Life Sciences Ltd.

NAS: TLSA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 16, 2022, 5:30 p.m.

/zigman2/quotes/207307745/composite

$

0.71

Change

-0.03 -3.68%

Volume

Volume 37

Quotes are delayed by 20 min

/zigman2/quotes/207307745/composite

Today's close

$ 0.75

$ 0.74

Change

-0.01 -1.53%

Day low

Day high

$0.71

$0.75

Open

52 week low

52 week high

$0.53

$2.10

Open

Insider Actions for Tiziana Life Sciences Ltd.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
10/05/2021 Gabriele Marco Antonio Cerrone
60,000   Acquisition at $0.52 per share. 31,050
10/04/2021 Gabriele Marco Antonio Cerrone
60,000   Acquisition at $0.55 per share. 33,000
10/04/2021 Gabriele Marco Antonio Cerrone
60,000   Acquisition at $0.5 per share. 30,000
10/01/2021 Gabriele Marco Antonio Cerrone
37,500   Acquisition at $0.49 per share. 18,300
09/27/2021 Gabriele Marco Antonio Cerrone
100,000   Acquisition at $0.52 per share. 52,000
05/20/2021 Gabriele Marco Antonio Cerrone
10,000   Acquisition at $0.71 per share. 7,100
12/09/2020 Gabriele Marco Antonio Cerrone
38,000   Acquisition at $0.78 per share. 29,640
11/18/2020 Gabriele Marco Antonio Cerrone
45,000   Acquisition at $0.84 per share. 37,800
02/03/2020 Gabriele Marco Antonio Cerrone
5,000   Acquisition at $2.37 per share. 11,850
01/13/2020 Gabriele Marco Antonio Cerrone
28,500   Acquisition at $0.43 per share. 12,255
12/31/2019 Gabriele Marco Antonio Cerrone
12,500   Acquisition at $2.79 per share. 34,875

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
5 Purchases
0 Sales
317,500
0

Officers and Executives

Mr. Gabriele Marco Antonio Cerrone
Executive Chairman & Chief Executive Officer
Ms. Keeren Shah
Finance Director
Dr. Vaseem A. Palejwala
Director-Clinical Operations
Dr. Matthew W. Davis
Chief Medical & Scientific Officer
Dr. Kunwar Shailubhai
Executive Director & Chief Scientific Officer
Mr. Hana Malik
Manager-Investor Relations & Business Development
Mr. Jules S. Jacob
Senior Director-CMC & Non Clinical Development
Mr. John Patrick Brancaccio
Independent Non-Executive Director
Mr. Willy Jules Simon
Independent Non-Executive Director
Link to MarketWatch's Slice.